Sodium Butyrate Supplement Boosts Weight Loss and Blood Sugar Control in New Trial
12-week study shows sodium butyrate enhanced weight loss in obesity and improved glucose control in type 2 diabetes patients.
Summary
A new clinical trial found that sodium butyrate supplements significantly enhanced weight loss in overweight adults without diabetes, with participants losing an average of 7 kg compared to 3.2 kg with placebo over 12 weeks. For those with type 2 diabetes, the supplement improved blood sugar control and reduced triglycerides, even without additional weight loss. Sodium butyrate is a short-chain fatty acid normally produced by gut bacteria during fiber fermentation. The study involved 46 adults who took either 1875 mg daily of sodium butyrate or placebo while following a reduced-calorie diet. Researchers used continuous glucose monitoring to track blood sugar patterns and found improved time spent in optimal glucose ranges for diabetic participants.
Detailed Summary
Sodium butyrate supplementation shows promise as a metabolic health intervention, according to a new randomized controlled trial that found distinct benefits for weight management and glucose control. This gut-derived compound, normally produced when beneficial bacteria ferment dietary fiber, may offer therapeutic potential when taken as a supplement.
Researchers conducted a 12-week double-blind study with 46 overweight and obese adults, half with type 2 diabetes. Participants received either 1875 mg daily of sodium butyrate or placebo while following identical reduced-calorie diets. The team measured body composition, metabolic markers, and used continuous glucose monitoring to track blood sugar patterns.
Results revealed striking differences based on diabetes status. Non-diabetic participants taking sodium butyrate lost significantly more weight (7.0 kg versus 3.2 kg with placebo). Those with type 2 diabetes didn't see enhanced weight loss but experienced meaningful metabolic improvements: triglyceride levels dropped substantially, and time spent in optimal glucose ranges (70-140 mg/dL) increased by 9%.
These findings suggest sodium butyrate may work through different pathways in healthy versus diabetic metabolism. The supplement appeared to enhance fat loss mechanisms in metabolically healthy individuals while improving glucose regulation and lipid metabolism in those with diabetes. Blood tests confirmed that oral supplementation successfully raised circulating butyrate levels.
For longevity-focused individuals, this research highlights how targeting the gut-metabolism axis might optimize metabolic health. However, the study's 12-week duration and modest sample size warrant larger, longer-term trials to establish optimal dosing and long-term safety profiles before widespread clinical adoption.
Key Findings
- Sodium butyrate enhanced weight loss by 119% in non-diabetic overweight adults (7.0 vs 3.2 kg)
- Type 2 diabetics saw 9% improvement in optimal glucose time and reduced triglycerides
- 1875 mg daily dosage successfully increased circulating butyrate levels in all participants
- Benefits occurred alongside calorie restriction, suggesting synergistic metabolic effects
Methodology
This was a 12-week randomized, double-blind, placebo-controlled trial with 46 adults (23 with type 2 diabetes) aged 30-70 with BMI 25-39.9. Participants received 1875 mg sodium butyrate daily or placebo with identical reduced-calorie diets. Continuous glucose monitoring tracked glycemic patterns.
Study Limitations
The 12-week study duration limits assessment of long-term effects and sustainability. Small sample size (23 per diabetes group) requires larger trials for definitive clinical recommendations. Generalizability beyond the specific population studied remains unclear.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.